Most of the patients presenting myocardial infarction would not be eligible for intensive lipid-lowering based on clinical algorithms or plasma C-reactive protein.

Atherosclerosis. 2011;214:148-50

Sposito AC, Alvarenga BF, Alexandre AS, Araújo AL, Santos SN, Andrade JM, Ramires JA, Quinaglia E Silva JC, Coelho OR, Brasilia Heart Study Group